Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin

Neoplasia

Volumn 10, Issue 1, 2008, Pages 61-68

  Rodrigues, Elaine G ^a   Dobroff, Andrey S S ^a   Cavarsan, Clarissa F ^a   Paschoalin, Thaysa ^a   Nimrichter, Leonardo ^b   Mortara, Renato A ^a   Santos, Edson Lucas ^a   Fázio, Marcos A ^a   Miranda, Antonio ^a   Daffre, Sirlei ^c   Travassos, Luiz R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO GOMESIN; DISULFIDE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL LINEAGE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 38649093034     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07885     Document Type: Article

References (36)

1. Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, and Chambers AF (2003). Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 82, 199-206.
2. Gottesman MM (2002). Mechanisms of cancer drug resistance. Ann Rev Med 53, 615-627.
3. Gottesman MM and Ling V (2006). The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580, 998-1009.
4. Folkman J (2006). Angiogenesis. Ann Rev Med 57, 1-18.
5. Ferrara N and Kerbel RS (2005). Angiogenesis as a therapeutic target. Nature 438, 967-974.
6. Mader JS and Hoskin DW (2006). Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15, 933-946.
7. Bulet P, Stocklin R, and Menin L (2004). Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198, 169-184.
8. Yount NY, Bayer AS, Xiong YQ, and Yeaman MR (2006). Advances in antimicrobial peptide immunobiology. Biopolymers 84, 435-458.
9. Lichtenstein A, Ganz T, Selsted ME, and Lehrer RI (1986). In vitro tumor-cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 68, 1407-1410.
10. Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, and Bdeir K (2004). Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J 18, 1306-1308.
11. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K, and Azuma I (1997). Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88, 184-190.
12. Eliassen LT, Berge G, Sveinbjornsson B, Svendsen JS, Vorland LH, and Rekdal O (2002). Evidence for a direct antitumor mechanism of action of bovine lactoferricin. Anticancer Res 22, 2703-2710.
13. Eliassen LT, Berge G, Leknessund A, Wikman M, Lindin I, Lokke C, Ponthan F, Johnsen JI, Sveinbjornsson B, Kogner P, et al. (2006). The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int J Cancer 119, 493-500.
14. Silva PI, Daffre S, and Bulet P (2000). Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem 275, 33464-33470.
15. Mandard N, Bulet P, Caille A, Daffre S, and Vovelle F (2002). The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur J Biochem 269, 1190-1198.
16. Fazio MA, Oliveira VX, Bulet P, Miranda MTM, Daffre S, and Miranda A (2006). Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Biopolymers 84, 205-218.
17. Moreira CK, Rodrigues FG, Ghosh A, Varotti FD, Miranda A, Daffre S, Jacobs-Lorena M, and Moreira LA (2007). Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp Parasitol 116, 346-353.
18. Lorenzini DM, Fukuzawa AH, da Silva PI, Machado-Santelli G, Bijovsky AT, and Daffre S (2003). Molecular cloning, expression analysis and cellular localization of gomesin, an anti-microbial peptide from hemocytes of the spider, Acanthoscurria gomesiana. Insect Biochem Mol Biol 33, 1011-1016.
19. Dobroff AS, Rodrigues EG, Moraes JZ, and Travassos LR (2002). Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells. Hybrid Hybridomics 21, 321-331.
20. Barros HC, Verbisck NV, DaSilva S, Araguth MF, and Mortara RA (1997). Distribution of epitopes of Trypanosoma cruzi amastigotes during the intracellular life cycle within mammalian cells. J Eukaryot Microbiol 44, 332-344.
21. Rodrigues EG, Silva LS, Fausto DM, Hayashi MS, Dreher S, Santos EL, Pesquero JB, Travassos LR, and Caires ACF (2003). Cyclopalladated compounds as chemotherapeutic agents: antitumor activity against a murine melanoma cell line. Int J Cancer 107, 498-504.
22. Soballe PW, Maloy WL, Myrga ML, Jacob LS, and Herlyn M (1995). Experimental local therapy of human melanoma with lytic magainin peptides. Int J Cancer 60, 280-284.
23. Steinstraesser L, Klein RD, Aminlari A, Fan MH, Khilanani V, Remick DG, Su GL, and Wang SC (2001). Protegrin-1 enhances bacterial killing in thermally injured skin. Crit Care Med 29, 1431-1437.
24. Wolf P, Rieger E, and Kerl H (1993). Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 28, 17-21.
25. Steinmann A, Funk JO, Schuler G, and von den DP (2000). Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 43, 555-556.
26. Hesling C, D'Incan M, Mansard S, Franck F, Corbin-Duval A, Chevenet C, Dechelotte P, Madelmont JC, Veyre A, Souteyrand P, et al. (2004). In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Br J Dermatol 150, 761-767.
27. Malek-Mansour S (1973). Remission of melanoma with D.N.C.B. treatment. Lancet 2, 503-504.
28. Illig L, Paul E, and Bodeker RH (1984). Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years). Anticancer Res 4, 293-298.
29. von Nida J and Quirk C (2003). Successful treatment of in-transit melanoma metastases using topical 2-4 dinitrochlorobenzene. Australas J Dermatol 44, 277-280.
30. Damian DL and Thompson JF (2007). Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone. J Am Acad Dermatol 56, 869-871.
31. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, et al. (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298, 1025-1029.
32. Moraes LG, Fazio MA, Vieira RF, Nakaie CR, Miranda MT, Schreier S, Daffre S, and Miranda A (2007). Conformational and functional studies of gomesin analogues by CD, EPR and fluorescence spectroscopies. Biochim Biophys Acta 1768, 52-58.
33. Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng CC, et al. (2000). Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55, 88-98.
34. Miranda A, Fázio MA, Miranda MTM, Daffre S, and Lamas WT (2004). Alanine series of the antimicrobial peptide gomesin: a structure-activity relationship study. In Peptides. M Flegel, M Fridkin, C Gilon, and J Slaninova (Eds.). Kenes International, Prague, pp. 493-494.
35. Fazio MA, Jouvensal L, Vovelle F, Bulet P, Miranda MT, Daffre S, and Miranda A (2006). Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Biopolymers 88, 386-400.
36. Mani R, Cady SD, Tang M, Waring AJ, Lehrer RI, and Hong M (2006). Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci USA 103, 16242-16247.